Peptidylarginine Deiminase Inhibitor Treatment is Associated with Increased Phage Susceptibility in Erwinia amylovora.

Ibrahim N, Svircev AM, Anany H, Weadge J

Open source

DOI
10.1139/cjm-2026-0025
Published
2026 Aug 26
Container
Canadian journal of microbiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1139/cjm-2026-0025,
  title = {Peptidylarginine Deiminase Inhibitor Treatment is Associated with Increased Phage Susceptibility in Erwinia amylovora.},
  author = {Ibrahim N and Svircev AM and Anany H and Weadge J},
  year = {2026},
  journal = {Canadian journal of microbiology},
  doi = {10.1139/cjm-2026-0025},
  url = {https://doi.org/10.1139/cjm-2026-0025}
}

RIS

TY  - JOUR
TI  - Peptidylarginine Deiminase Inhibitor Treatment is Associated with Increased Phage Susceptibility in Erwinia amylovora.
AU  - Ibrahim N
AU  - Svircev AM
AU  - Anany H
AU  - Weadge J
PY  - 2026
JO  - Canadian journal of microbiology
DO  - 10.1139/cjm-2026-0025
UR  - https://doi.org/10.1139/cjm-2026-0025
ER  - 

APA

N, I., AM, S., H, A., & J, W. (2026). Peptidylarginine Deiminase Inhibitor Treatment is Associated with Increased Phage Susceptibility in Erwinia amylovora.. Canadian journal of microbiology. https://doi.org/10.1139/cjm-2026-0025

Source records